# Haisong Capital

> Haisong Capital is a VC fund backing Manufacturing, Semiconductor and Pharmaceutical. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 9
- Last investment: May 2023
- Lead investor: 33%
- Last updated: Aug 2026

Haisong Capital is a VC fund focused on Manufacturing and Semiconductor. Haisong Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 4 | 44% |
| Semiconductor | 2 | 22% |
| Pharmaceutical | 2 | 22% |
| Gaming | 1 | 11% |
| Medical | 1 | 11% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 33% |
| Series A | 2 | 22% |
| Series B | 2 | 22% |
| Angel | 1 | 11% |
| Series C | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Blue Wave | Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips. | $14.5M | Seed | May 04, 2023 |  |
| Qinghai Lihao | Qinghai Lihao engages in the process technology research and development, production, sales and related supporting new energy business. | $306.5M | Series B | Sep 27, 2022 |  |
| Aqronos | Aqronos is an unmanned technology R&D company, mainly engaged in the research and development and application of unmanned technology |  | Series A | May 30, 2022 |  |
| Lisuan Technology | Liansu Technology mainly develops graphics rendering GPUs. | $15.8M | Angel | Feb 23, 2022 |  |
| Yingmai Medical | Yingmai Medical engages in the research, development, innovation, and manufacturing of medical devices. |  | Series B | Oct 25, 2021 |  |
| Juventas | Juventas is a provider and developer of innovative immune cell therapeutic drugs. The company's first investigational new drug application for the cell therapeutic product CNCT19 has been officially accepted by the National Medical Products Administration. Comprehensive product pipelines will be developed and promoted constantly to provideeffective treatment for malignant hematological neoplasms such as leukemia and lymphoma. | $63.3M | Series C | Jul 12, 2021 |  |
| Weilong Foods | Weilong Foods is a snack food brand that produces and manufactures spicy noodles, dried seafood, and other series of snack foods. The company was founded in 1999 by Liu Weiping and Liu Fuping in Luohe, Henan Province. | $558M | Series A | May 13, 2021 |  |
| Pro-Heal Pharmaceuticals | Pro-Heal Pharmaceuticals is a biotechnology based pharmaceutical manufacturing company. |  | Seed | Mar 01, 2021 |  |
| Moore Threads | Moore Threads is providing Graphics Processing Unit technology and services to corporate clients in a wide variety of sectors such as gaming, the creative industry, and artificial intelligence. The company was founded in 2020 and is based in Beijing, China. |  | Seed | Feb 25, 2021 |  |

9 of 9 investments shown.

## Co-investors
- [Oceanpine Capital](https://shizune.co/investors/profile/oceanpine-capital) — VC Fund, 5 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 2 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 2 deals together
- [Anchuang Investment](https://shizune.co/investors/profile/anchuang-investment) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [Black Oak Capital](https://shizune.co/investors/profile/black-oak-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Haisong Capital invest in?

Haisong Capital invests primarily in Manufacturing, Semiconductor and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Haisong Capital last invest?

The most recent investment recorded for Haisong Capital closed in May 2023. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co